Beryl Kende LCSW

Recommended Articles

• Breastfeeding Children Can Reduce Their Risk of Developing Infections

  Babies who are exclusively breastfed have fewer and less severe infections, when compared to babies who are partially breastfed or not breastfed at all, according to a study published in, Archives of Disease in Childhood. This protection is regardless of the healthcare and vaccinations provided to...

• All About Bronchopneumonia

  Pneumonia is an infection of the lung tissue, which can be caused by bacteria, viruses, and fungi. There are two types of pneumonia: lobar pneumonia and bronchopneumonia. Lobar pneumonia is when an entire lobe or more than one lobe of the lung gets involved. Bronchopneumonia happens when the bronchi...

• Mass Casualty Training for Healthcare Professionals After Vegas Shooting

  The Las Vegas shooter is said to have perpetrated the worst mass casualty shooting in recent US history. At the end of his shooting rampage, he had left fifty-nine dead and over five hundred wounded, many of them on the critical list. The Las Vegas area only has one Level I trauma center and they...

• Activity Trackers Deemed Helpful For Rheumatic Diseases

  When it comes to a rheumatic disease, such as rheumatoid arthritis (RA), taking any steps can cause pain. But now, researchers are stressing that certain apps and digital tools, like activity trackers, can have a positive impact on individuals with chronic arthritis. An activity tracker, also known...

• Health Reasons That Can Make a Person Pass Out

  Causes of Fainting A person faints or loses consciousness for a brief time when the brain does not get enough oxygen. Fainting or passing out is also medically called syncope. Before fainting, people may experience lightheadedness, dizziness, weakness, and nausea. Others describe fainting as...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...